Showing results (291-300 of 311) with videos related to

Sort By:
Pageof 32
Neuro-Oncology Advances|October 26, 2022
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastomaLazaros Lazaridis, Elisabeth Bumes, Dorothee Cäcilia Spille, et al.
Neuro-Oncology|November 10, 2017
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastomaNiklas Schäfer, Martin Proescholdt, Joachim P Steinbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2023
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical TrialConstantin Roder, Walter Stummer, Jan Coburger, et al.
Neurological Research and Practice|July 24, 2025
Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational studyChristoph Oster, Aylin Matyar, Teresa Schmidt, et al.
Neuro-Oncology|February 3, 2023
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatmentMalte Träger, Leonille Schweizer, Eilís Pérez, et al.
Nature Communications|August 23, 2025
Multi-omic identification of perineurial hyperplasia and lipid-associated nerve macrophages in human polyneuropathiesMichael Heming, Anna-Lena Börsch, Jolien Wolbert, et al.
Acta Neuropathologica|July 7, 2018
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytomaPhilipp Sievers, Damian Stichel, Daniel Schrimpf, et al.
Journal of Neurosurgery. Spine|June 26, 2026
Oncological and neurological outcomes after parent rootlet resection in functionally critical spinal schwannomas: a retrospective multicenter comparative studyJuan Carlos Galeano Zapata, Emanuele Maragno, Marco Gallus, et al.
Neuro-Oncology|October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Pageof 32